Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
Clinical trial NCT05974410 · AVAILABLE
Trial details
- NCT number
- NCT05974410
- Sponsor
- AVM Biotechnology Inc
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.